Matthew Kiernan is professor of neurology at the University of New South Wales, Australia, and directs the multidisciplinary motor neurone disease clinical service at Prince of Wales Hospital. He was involved in the development and launched the Australian motor neurone disease registry. In addition to this clinical interest in MND, his research focus explores the pathophysiology of neurodegenerative disease, leading to the recent initiation of an investigator driven clinical trial of a novel neuroprotective therapy, supported by the National Health and Medical Research Council of Australia. He is chair of the scientific committee of the Australian Brain Foundation, allocating funds to research and medical education for the treatment and prevention of neurological disorders, chair of the scientific and programme committee of the Australian and New Zealand Association of Neurologists, and editor of the Journal of Neurology, Neurosurgery and Psychiatry.

Competing Interests

Have you in the past five years accepted the following from an organisation that may in any way gain or lose financially from the publication of papers in the BMJ?

Reimbursement for attending a symposium?
No

A fee for speaking?
No

A fee for organising education?
No

Funds for research?
No

Funds for a member of staff?
No

Fees for consulting?
No

Have you in the past five years been employed by any organisation that may in any way gain or lose financially from the publication of papers in the BMJ?
No

Do you hold any stocks or shares in an organisation?
No

Do you have any other competing financial interests?
No

I have no competing interests.